Nolvadex 54965-24-1 Tamoxifen Citrate Anti-estrogen Steroids - Product

Other Specification :  Nolvadex 54965-24-1 Tamoxifen Citrate Anti-estrogen Steroids Quick Detail: 1. CAS: 54965-24-1 2. EINECS: 259-415-2 3. Assay: 99%-101%. 4. MF: C32H37NO8 5. Character: White Crystalline Powder. 6. Usage: For The Treatment Of Advanced, Recurrent Breast Cancer And Ovarian Cancer And Other Illnesses. Used As An Antineoplastic Raw Materials. Biological Activity: Estrogen Receptor Antagonist/partial Agonist. Selective And Potent Inhibitor Of Mammalian Sterol Isomerase. Neuroprotective In Female Rats In Vivo . Also High Affinity Agonist At The Membrane Estrogen Receptor GPR30. Description: Nolvadex (tamoxifen Citrate) Is Very Comparable To Clomid, Behaves In The Same Manner In All Tissues, And Is A Mixed Estrogen Agonist/antagonist Of The Same Type As Clomid. The Two Molecules Are Also Very Similar In Structure. It Is Not Correct That Nolvadex Reduces Levels Of Estrogen: Rather, It Blocks Estrogen From Estrogen Receptors And, In Those Tissues Where It Is An Antagonist, Causes The Receptor To Do Nothing. The Claim That Nolvadex Reduces Gains Should Not Be Taken Too Seriously. The Fact Is That Any Number Of Bodybuilders Have Made Excellent Gains While Using Nolvadex. The Belief That It Reduces Gains Seems To Stem From The Fact That The Scientific Literature Reports A Slight Reduction In IGF-1 (individuals Using Anabolic Steroids Were Not Studied Though) From Use Of Nolvadex. Thus, Dan Duchaine Reported That It Reduces IGF-1 And Therefore Reduces Gains. However, If This Effect Exists At All, It Must Be Very Minor, Due To The Excellent Gains That Many Have Made, And From The Fact That No One Has Noticed Any Such Thing From Clomid, Which Has The Same Activity Profile. However, I Would Not Be Surprised If One Were To Tell A Steroid User That Clomid Reduced His Gains, He Would Immediately Become Afraid That Clomid Reduced His Ga

View Profile